Christoph Wanner

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.3Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice

Journal of Diabetes and its Complications(2023)10.1016/j.jdiacomp.2023.108411

Top 15%

1.3DataRank

Top 15%28 citations

Sankar D. Navaneethan, Susanne B. Nicholas, Kevin M. Pantalone, Christoph Wanner, Stefanie Hamacher +3 more

Papers

Driven by 28 papers — median percentile 85. Top paper: “Data Sharing Under the General Data Protection Regulation”.

Data Sharing Under the General Data Protection Regulation

Hypertension(2021)10.1161/hypertensionaha.120.16340

N/A

5.8DataRank · unranked

133 citations

Dara Hallinan, Rolf Apweiler, Angel Argiles, Joachim Beige, Ariela Benigni +37 more

Finerenone in Predominantly Advanced CKD and Type 2 Diabetes With or Without Sodium-Glucose Cotransporter-2 Inhibitor Therapy

Kidney International Reports(2021)10.1016/j.ekir.2021.10.008

N/A

4.8DataRank · unranked

165 citations

Gerasimos Filippatos, Rajiv Agarwal, Stefan D. Anker, Bertram Pitt, Luís M. Ruilope +10 more

Short‐Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA‐REG OUTCOME Trial

Journal of the American Heart Association(2020)10.1161/jaha.120.016976

N/A

2.4DataRank · unranked

74 citations

Di Xie, Silvio E. Inzucchi, Bernard Zinman, Audrey Koitka‐Weber, Michaela Mattheus +5 more

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial

Diabetes Care(2020)10.2337/dc20-0279

N/A

1.9DataRank · unranked

61 citations

Robert D. Toto, Mark E. Cooper, Johannes F.E. Mann, Julio Rosenstock, Darren K. McGuire +12 more

Effects of canagliflozin versus finerenone on cardiorenal outcomes: exploratory post hoc analyses from FIDELIO-DKD compared to reported CREDENCE results

Nephrology Dialysis Transplantation(2021)10.1093/ndt/gfab336

N/A

1.7DataRank · unranked

62 citations

Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt, Peter Rossing, Luís M. Ruilope +12 more

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine(2015)10.1056/nejmoa1504720

N/A

1.4DataRank · unranked

11839 citations

Christoph Wanner, John M. Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel +7 more

Safety of Empagliflozin in Patients With Type 2 Diabetes and Chronic Kidney Disease: Pooled Analysis of Placebo-Controlled Clinical Trials

Diabetes Care(2022)10.2337/dc21-2034

N/A

1.4DataRank · unranked

44 citations

Adeera Levin, Masaomi Nangaku, Takashi Kadowaki, Rajiv Agarwal, Sibylle J. Hauske +6 more

Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD

Journal of the American Society of Nephrology(2023)10.1681/asn.0000000000000271

N/A

1.4DataRank · unranked

45 citations

Natalie Staplin, David Keane, Christoph Wanner, Susanne Brenner, Vladimir Cejka +25 more

Design and rationale of FINE-REAL: A prospective study of finerenone in clinical practice

Journal of Diabetes and its Complications(2023)10.1016/j.jdiacomp.2023.108411

Top 15%

1.3DataRank

Top 15%28 citations

Sankar D. Navaneethan, Susanne B. Nicholas, Kevin M. Pantalone, Christoph Wanner, Stefanie Hamacher +3 more

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study

Diabetes Care(2022)10.2337/dc21-1944

N/A

1.2DataRank · unranked

35 citations

Ellen Burgess, Rajiv Agarwal, Stefan D. Anker, Gerasimos Filippatos, Bertram Pitt +92 more

Analysis of on-treatment cancer safety events with daprodustat versus conventional erythropoiesis-stimulating agents—post hoc analyses of the ASCEND-ND and ASCEND-D trials

Nephrology Dialysis Transplantation(2022)10.1093/ndt/gfac342

N/A

0.767DataRank · unranked

11 citations

Finnian R. Mc Causland, Brian Claggett, Christoph Wanner, Andrzej Więcek, Michael B. Atkins +13 more

Early Benefits of Empagliflozin in Patients with or Without Heart Failure: Findings from EMPA-REG OUTCOME

ESC Heart Failure(2020)10.1002/ehf2.12891

N/A

0DataRank · unranked

20 citations

Anne Pernille Ofstad, David Fitchett, Cordula Zeller, Christoph Wanner, Jyothis T. George +4 more

High Oxalate Concentrations Correlate with Increased Risk for Sudden Cardiac Death in Dialysis Patients

Journal of the American Society of Nephrology(2021)10.1681/asn.2020121793

N/A

0DataRank · unranked

46 citations

Theresa Ermer, Steven G. Coca, Maria Clarissa Tio, Bernd Genser, Martin Reichel +9 more

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Kidney International(2020)10.1016/j.kint.2020.07.013

N/A

0DataRank · unranked

119 citations

Rajiv Agarwal, William G. Herrington, Hiddo J.L. Heerspink, Johannes F.E. Mann, Shahnaz Shahinfar +76 more

SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation

Diabetes(2020)10.2337/dbi20-0040

N/A

0DataRank · unranked

124 citations

Frank C. Brosius, Matthew A. Cavender, Paola Fioretto, Kevin Fowler, Hiddo J.L. Heerspink +12 more

A meta-analysis of GFR slope as a surrogate endpoint for kidney failure

Nature Medicine(2023)10.1038/s41591-023-02418-0

N/A

0DataRank · unranked

160 citations

Willem Collier, Tom Greene, Shiyuan Miao, Juhi Chaudhari, Gerald B. Appel +79 more

Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Kidney International(2023)10.1016/j.kint.2023.05.010

N/A

0DataRank · unranked

49 citations

Yolanda T. Becker, Klemens Budde, Bertram L. Kasiske, Bryce Kiberd, Alexandre Loupy +46 more

Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment

Kidney International(2020)10.1016/j.kint.2020.06.024

N/A

0DataRank · unranked

283 citations

Maria Luiza Caramori, Juliana C.N. Chan, Hiddo J.L. Heerspink, Clint Hurst, Kamlesh Khunti +19 more

Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone

JAMA Cardiology(2023)10.1001/jamacardio.2023.1505

N/A

0DataRank · unranked

35 citations

Bertram Pitt, Peter Rossing, Stefan D. Anker, Gerasimos Filippatos, Luís M. Ruilope +10 more

Characterization and implications of the initial estimated glomerular filtration rate ‘dip’ upon sodium-glucose cotransporter-2 inhibition with empagliflozin in the EMPA-REG OUTCOME trial

Kidney International(2020)10.1016/j.kint.2020.10.031

N/A

0DataRank · unranked

212 citations

Matthew R. Weir, George L. Bakris, Michaela Mattheus, David Z.I. Cherney, Naveed Sattar +8 more

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

Circulation(2024)10.1161/circulationaha.124.069568

N/A

0DataRank · unranked

168 citations

Yu Mi Kang, KyungAh Im, Brendon L. Neuen, Stefan D. Anker, Deepak L. Bhatt +24 more

Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis

Circulation(2024)10.1161/circulationaha.124.069556

N/A

0DataRank · unranked

88 citations

Simon Wandel, Peter Willeit, Anastasia Lesogor, Keith Bailey, Paul M. Ridker +8 more

Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial

Nephrology Dialysis Transplantation(2024)10.1093/ndt/gfae132

N/A

0DataRank · unranked

79 citations

Rajiv Agarwal, George L. Bakris, David Z.I. Cherney, Carolyn S.P. Lam, Brendon L. Neuen +95 more

A meta-analysis of randomized controlled clinical trials for implications of acute treatment effects on glomerular filtration rate for long-term kidney protection

Kidney International(2024)10.1016/j.kint.2024.05.024

N/A

0DataRank · unranked

12 citations

Devin Eddington, Juhi Chaudhari, Raymond O. Estacio, Enyu Imai, Marián Goicoechea +16 more

Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Kidney International(2025)10.1016/j.kint.2025.04.005

N/A

0DataRank · unranked

43 citations

José Manuel Arreola Guerra, Juliana C.N. Chan, Vivekanand Jha, Holly Kramer, Susanne B. Nicholas +62 more

Carbamylated Albumin, Heart Failure, and Mortality in Patients Undergoing Coronary Angiography

Clinical Chemistry(2025)10.1093/clinchem/hvaf021

N/A

0DataRank · unranked

5 citations

Graciela Delgado, Anders H. Berg, Christoph Wanner, Bernhard K. Krämer, Winfried März +3 more

Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial

Clinical Kidney Journal(2020)10.1093/ckj/sfaa225

N/A

0DataRank · unranked

18 citations

Mark E. Cooper, Odd Erik Johansen, Robert D. Toto, Julio Rosenstock, Darren K. McGuire +12 more

Protein carbamylation is associated with increased mortality and CKD progression in patients with CKD: results from the EQUAL study

Clinical Kidney Journal(2025)10.1093/ckj/sfaf302

N/A

0DataRank · unranked

3 citations

AR Haas, Nicholas C Chesnaye, Kitty J. Jager, Fergus Caskey, Maria Pippias +10 more

Christoph Wanner

Indexed papers

Top data-sharing exemplar

Papers